Quantitative Systematic Strategies’s Teva Pharmaceuticals TEVA Stock Holding History

Quantitative Systematic Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-31,058	Closed	-$279K	–	618
2020 Q1	$279K	Buy	+31,058	New	+$318K	0.23%	160
2016 Q1	–	Sell	-4,560	Closed	-$301K	–	738
2015 Q4	$301K	Sell	4,560 -2,443	-35%	-$151K	0.08%	764
2015 Q3	$395K	Buy	7,003 +266	+4%	+$17.2K	0.19%	220
2015 Q2	$400K	Sell	6,737 -8,389	-55%	-$518K	0.09%	362
2015 Q1	$946K	Buy	15,126 +11,598	+329%	+$674K	0.26%	132
2014 Q4	$202K	Buy	+3,528	New	+$197K	0.08%	289
2014 Q3	–	Sell	-5,645	Closed	-$298K	–	383
2014 Q2	$298K	Buy	+5,645	New	+$289K	0.21%	188

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's TEVA Position: Q2 2020 in Review

Quantitative Systematic Strategies sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 31,058 shares — an estimated $279K sold.

Quantitative Systematic Strategies first reported a position in TEVA in Q2 2014 and held it in 7 quarters. The position peaked at $946K in Q1 2015. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

Quantitative Systematic Strategies reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 31,058 Teva Pharmaceuticals shares in Q2 2020, an estimated $279K.
Quantitative Systematic Strategies first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 7 quarters.
Quantitative Systematic Strategies's Teva Pharmaceuticals position peaked at $946K in Q1 2015.
455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2020, filed 4 Aug 2020.